Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ABP 501
ABP 501
Amgen Gets EU Nod for Humira Biosimilar
Investopedia
Mon, 01/30/17 - 10:54 pm
Amgen
Humira
biosimilars
ABP 501
Amgen's Biosimilar Approval And Astra's Anti-PD-L1 Data
Seeking Alpha
Sun, 09/18/16 - 09:54 am
Amgen
biosimilars
AstraZeneca
anti-PD-L1
ABP 501
Humira
durvalumab
FDA Panel Resoundingly Backs Amgen's Biosimilar Humira
Investors.com
Tue, 07/12/16 - 07:03 pm
FDA
advisory panels
Amgen
biosimilars
Humira
ABP 501
Amgen drug appears 'highly similar' to Humira -FDA staff
Yahoo/Reuters
Fri, 07/8/16 - 10:23 am
Amgen
Humira
FDA
Enbrel
rheumatoid arthritis
ABP 501
biosimilars
FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501
Yahoo
Mon, 01/25/16 - 10:22 pm
FDA
Amgen
biosimilars
biologics
ABP 501
Humira
The 3 Most Important Drugs in Amgen's Pipeline
Motley Fool
Fri, 12/4/15 - 08:17 pm
Amgen
ABP 501
Omecamtiv Mecarbil
Kyprolis
Amgen's First Biosimilar Marketing Authorization Application Submitted To European Medicines Agency For ABP 501
Yahoo
Fri, 12/4/15 - 01:40 pm
Amgen
biosimilars
Europe
Humira
ABP 501
Why AbbVie was not Impacted by Amgen Humira Biosimilar Submission
Bidness, ETC
Mon, 11/30/15 - 09:27 am
AbbVie
Humira
Amgen
biosimilars
ABP 501
Can Amgen's marketing muscle vault its Humira biosim ahead of rivals?
Fierce Pharma Marketing
Wed, 10/15/14 - 11:13 am
Amgen
biosimilars
Humira
ABP 501
Novartis
Boehringer Ingelheim
Phase 3 successful for Amgen's adalimumab biosimilar
Seeking Alpha
Wed, 10/8/14 - 10:09 am
Amgen
adalimumab
biosimilars
Humira
ABP 501